You write, "According to the Telegraph, the NHS will respond to the price increase by prescribing Mounjaro to more people."
I doubt very much that the NHS will "respond to" the price increase. But NICE is consulting on an update to its guidance for Type 2 diabetes, and its revised recommendations are likely to mean more people being prescribed GLP-1 agonists like Mounjaro.
Really insightful breakdown so many private users may now face tough choices as Mounjaro’s cost triples overnight. Worth weighing up your health status with some simple screenings like thyroid, blood glucose or vitamin D before diving further: https://www.shemed.co.uk/blog/is-your-health-stopping-you-from-losing-weight-heres-what-to-check
You write, "According to the Telegraph, the NHS will respond to the price increase by prescribing Mounjaro to more people."
I doubt very much that the NHS will "respond to" the price increase. But NICE is consulting on an update to its guidance for Type 2 diabetes, and its revised recommendations are likely to mean more people being prescribed GLP-1 agonists like Mounjaro.